Standard BioTools Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $101.9M | $104.4M | $114.7M | $116.5M | $71.2M | $52.3M | $42.9M | $33.6M |
| Cost of Revenue | $50.0M | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $100.0K | $11.6M |
| Gross Profit | $52.0M | $58.4M | $114.4M | $116.2M | $70.9M | $52.0M | $42.8M | $22.0M |
| Gross Margin | 51.0% | 55.9% | 99.7% | 99.7% | 99.6% | 99.4% | 99.8% | 65.5% |
| Operating Expenses | ||||||||
| Research & Development | $30.8M | $38.4M | $39.3M | $43.4M | $20.0M | $16.6M | $13.9M | $13.0M |
| SG&A Expense | $79.5M | $93.2M | $83.0M | $71.3M | $48.4M | $38.5M | $31.3M | $23.5M |
| Operating Income | $-58.4M | $-73.2M | $-50.2M | $-51.8M | $-18.7M | $-18.1M | $-18.6M | $-14.6M |
| Operating Margin | -57.3% | -70.1% | -43.7% | -44.5% | -26.2% | -34.5% | -43.3% | -43.4% |
| Interest Expense | $5.8M | $5.8M | $5.8M | $5.3M | $14.0K | $628.0K | $3.1M | $2.2M |
| Pretax Income | $-63.8M | $-80.2M | $-54.8M | $-57.7M | $-16.4M | $-18.9M | $-22.3M | $-16.8M |
| Income Tax Expense | $-3.3M | $-4.2M | $-1.5M | $-4.9M | $137.0K | $136.0K | $166.0K | $83.0K |
| Net Income | $-60.5M | $-76.0M | $-53.3M | $-52.8M | $-16.5M | $-19.0M | $-22.5M | $-16.9M |
| Net Margin | -59.4% | -72.8% | -46.5% | -45.4% | -23.2% | -36.4% | -52.4% | -50.4% |
| EPS (Basic) | $-0.46 | $-0.66 | $-0.47 | $-0.48 | $-0.16 | $-0.22 | $-0.45 | $-2.24 |
| EPS (Diluted) | $-0.46 | $-0.66 | $-0.47 | $-0.48 | $-0.16 | $-0.22 | $-0.45 | $-2.24 |
| Shares Outstanding (Basic) | 155.1M | 116.8M | 115.4M | 113.4M | 103.2M | 100.5M | 81.3M | 7.7M |
| Shares Outstanding (Diluted) | 155.1M | 116.8M | 115.4M | 113.4M | 103.2M | 100.5M | 81.3M | 7.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |